KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Royalty Pharma (RPRX) Amortization - Intangibles: 2019-2022

Historic Amortization - Intangibles for Royalty Pharma (RPRX) over the last 3 years, with Mar 2022 value amounting to $5.7 million.

  • Royalty Pharma's Amortization - Intangibles fell 0.02% to $5.7 million in Q1 2022 from the same period last year, while for Mar 2022 it was $23.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $5.7 million for FY2022, which is 75.34% down from last year.
  • Per Royalty Pharma's latest filing, its Amortization - Intangibles stood at $5.7 million for Q1 2022, which was down 2.17% from $5.8 million recorded in Q4 2021.
  • Royalty Pharma's Amortization - Intangibles' 5-year high stood at $6.6 million during Q2 2019, with a 5-year trough of $5.7 million in Q1 2022.
  • Over the past 3 years, Royalty Pharma's median Amortization - Intangibles value was $5.7 million (recorded in 2021), while the average stood at $5.7 million.
  • Data for Royalty Pharma's Amortization - Intangibles shows a maximum YoY dropped of 13.12% (in 2020) over the last 5 years.
  • Quarterly analysis of 4 years shows Royalty Pharma's Amortization - Intangibles stood at $5.8 million in 2019, then remained steady at $5.8 million in 2020, then remained steady at $5.8 million in 2021, then decreased by 0.02% to $5.7 million in 2022.
  • Its Amortization - Intangibles stands at $5.7 million for Q1 2022, versus $5.8 million for Q4 2021 and $5.8 million for Q3 2021.